Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
J Appl Toxicol ; 40(8): 1060-1066, 2020 08.
Artigo em Inglês | MEDLINE | ID: mdl-32150766

RESUMO

Andiroba (Carapa guianensis Aubl) is an Amazonian plant whose oil has been widely used in traditional medicine for various purposes, including anti-inflammation. Research reports indicate that the oil can confer antitumor activity due to the presence of fatty acids, which can directly influence cell death mechanisms. Thus, andiroba oil (AO) has gained interest for its potential to be used in antineoplastic therapies. Here, we report an in vitro analysis of the cytotoxic and mutagenic potential of AO in the gastric cancer cell line, ACP02. Cell survival was assessed by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay, differential staining with ethidium bromide and acridine orange assessed apoptosis-necrosis, and mutagenesis was assessed by the micronucleus test. The apolar oil was first diluted in 0.1% dimethyl sulfoxide (DMSO) and then further diluted to six concentrations (0.01, 0.1, 1, 10 and 100 µg/mL and 1 mg/mL) in RPMI medium. Controls included RPMI alone (negative control) and 0.1% DMSO diluted in medium (vehicle control). The MTT test showed that AO significantly reduced cell viability (P < .05) only when the highest tested concentration was applied for 48 hours. The apoptosis/necrosis test showed that the highest concentration of AO induced cell death by apoptosis at 24 and 48 hours. There was no statistically significant increase in the frequency of micronuclei. The ability of the AO to decrease the viability of ACP02 cells via apoptosis, without exerting mutagenic effects, suggests that the oil could be useful as an alternative therapeutic agent for primary tumors of stomach cancer.


Assuntos
Apoptose/efeitos dos fármacos , Citotoxicidade Imunológica/efeitos dos fármacos , Citotoxinas/toxicidade , Meliaceae/toxicidade , Mutagênese/efeitos dos fármacos , Mutagênicos/toxicidade , Óleos de Plantas/toxicidade , Neoplasias Gástricas/tratamento farmacológico , Antineoplásicos/uso terapêutico , Brasil , Células Cultivadas/efeitos dos fármacos , Humanos , Meliaceae/química , Óleos de Plantas/química , Plantas Medicinais/química , Plantas Medicinais/toxicidade
3.
Chemosphere ; 199: 35-43, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29428514

RESUMO

Toxicological screening of Swietenia mahagoni Jacq. (Meliaceae, West Indies Mahogany) against the lepidopteran pest Spodoptera litura was examined. Phytochemical screening through GC-MS analysis revealed nine peaks with prominent peak area % in Bis (2-ethylhexyl) phthalate (31.5%) was observed. The larvae exposed to discriminating dosage of 100 ppm deliver significant mortality rate compare to other treatment concentrations. The lethal concentrations (LC50 and LC90) was observed at the dosage of 31.04 and 86.82 ppm respectively. Sub-lethal concentrations (30 ppm) showed higher larval and pupal durations. However, pupal weight and mean fecundity rate reduced significantly. Similarly, the adult longevity reduced significantly in dose dependent manner. Midgut histology studies showed that the methanolic extracts significantly disturbs the gut epithelial layer, lumen and brush border membrane compare to the control. The soil assay on a non-target beneficial organism, the soil indicator earthworm Eudrilus eugeniae, with extracts from S. mahagoni (200 mg/kg) showed no toxicity compared to Monocrotophos at the dosage of 10 ppm/kg. Current results suggest that this bio-rational plant product from S. mahagoni displays a significant effect to reduce lepidopteran pests with low toxicity to other beneficial species.


Assuntos
Meliaceae/toxicidade , Oligoquetos/efeitos dos fármacos , Spodoptera/efeitos dos fármacos , Animais , Cromatografia Gasosa-Espectrometria de Massas , Inseticidas/farmacologia , Larva/efeitos dos fármacos , Compostos Fitoquímicos/análise , Extratos Vegetais/toxicidade , Pupa/efeitos dos fármacos , Índias Ocidentais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA